Fulgent Pharma is a clinical stage pharmaceutical company focused on developing and commercializing innovative cancer therapeutics. Our pipeline includes both improved chemotherapy drugs through nanoencapsulation and innovative new drug candidates, all of which are targeted at treating a broad range of cancers, including breast, lung, ovarian, colon, and pancreatic cancer.